These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1010 related items for PubMed ID: 16812979

  • 21. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 22. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 23. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA, VALIANT Investigators.
    Am Heart J; 2005 Aug; 150(2):323-9. PubMed ID: 16086938
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 25. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE, Dahlström U, Gøtzsche O, Lahiri A, Skagen K, Andersen GS, Egstrup K, OPTIMAAL Study Group.
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [Abstract] [Full Text] [Related]

  • 26. Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?
    Pfeffer MA.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S41-3. PubMed ID: 17199221
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 28. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 29. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML, EUROPA investigators.
    Int J Cardiol; 2007 Sep 14; 121(1):57-61. PubMed ID: 17270296
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug 14; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

  • 31. Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction.
    Onodera H, Matsunaga T, Tamura Y, Maeda N, Higuma T, Sasaki S, Mori Y, Yoshimachi F, Ishizaka H, Hanada H, Osanai T, Okumura K.
    Am Heart J; 2005 Oct 14; 150(4):689. PubMed ID: 16209966
    [Abstract] [Full Text] [Related]

  • 32. Beneficial effects of early coronary reperfusion on left ventricular remodeling and systolic function in patients with acute myocardial infarction.
    Yang Y, Gao R, Tian J, Xu Y, Chen Z, Yao K, Chen J.
    Chin Med J (Engl); 1998 Feb 14; 111(2):142-6. PubMed ID: 10374375
    [Abstract] [Full Text] [Related]

  • 33. ACE inhibitors in heart failure: what more do we need to know?
    Demers C, Mody A, Teo KK, McKelvie RS.
    Am J Cardiovasc Drugs; 2005 Feb 14; 5(6):351-9. PubMed ID: 16259523
    [Abstract] [Full Text] [Related]

  • 34. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.
    N Engl J Med; 2004 Sep 23; 351(13):1285-95. PubMed ID: 15385655
    [Abstract] [Full Text] [Related]

  • 35. On target to dual block RAS?
    Papadopoulos DP, Papademetriou V, Makris TK.
    Angiology; 2004 Sep 23; 60(6):739-49. PubMed ID: 19144653
    [Abstract] [Full Text] [Related]

  • 36. Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction.
    Ovricenco E, Sinescu C, Dinescu S.
    J Med Life; 2008 Sep 23; 1(3):323-33. PubMed ID: 20108509
    [Abstract] [Full Text] [Related]

  • 37. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X, Saini HK, Wang J, Gupta SK, Goyal RK, Dhalla NS.
    Expert Rev Cardiovasc Ther; 2005 Jul 23; 3(4):717-32. PubMed ID: 16076281
    [Abstract] [Full Text] [Related]

  • 38. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.
    Clin Ther; 2006 Nov 23; 28(11):1812-9. PubMed ID: 17213001
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
    Suzuki H.
    Ther Adv Cardiovasc Dis; 2009 Oct 23; 3(5):397-405. PubMed ID: 19491138
    [Abstract] [Full Text] [Related]

  • 40. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr 23; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.